| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 49,975 | 50,17 | 19:05 | |
| 49,980 | 50,17 | 19:05 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18:15 | Moderna startet Phase-1-Studie mit Ebola-Impfstoffkandidat | Moderna hat eine Phase-1-Studie mit seinem Impfstoffkandidaten mRNA-1469 gegen das Bundibugyo-Ebolavirus (BDBV) begonnen. Nach der Genehmigung durch die kanadische Gesundheitsbehörde wurden in Kanada... ► Artikel lesen | |
| 17:02 | Moderna, Inc.: Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus | Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines indicatedPhase 1 trial is being conducted in Canada as part of our expanded collaboration... ► Artikel lesen | |
| Mo | Moderna: Revenue Reaches $145 Million As Quarterly Operating Loss Tops $800 Million Ahead Of Flu Vaccine Decision | ||
| Sa | July healthcare recap: Regeneron, DexCom shine as Moderna, managed-care stocks retreat | ||
| Fr | Moderna, Inc. - 10-Q, Quarterly Report |
